 WALTHAM, Mass., Sept. 27, 2022 GLOBE NEWSWIRE -- Dyne Therapeutics, Inc. Nasdaq: DYN, a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at Chardans 6th Annual Genetic Medicines Conference being held in New York, NY on Tuesday, October 4, 2022 at 8:00 a.m. ET. 